| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |